L. Tarcsay

发表

Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08.

C. S. Wang, P. Alaupovic, L. Tarcsay, 1973, Biochemistry.

Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptide

R. Landmann, H. Towbin, H. Denz, 1993, Biotherapy.

Maintenance of intestinal epithelium structural integrity and mucosal leukocytes during chemotherapy by oral administration of muramyl tripeptide phosphatidylethanolamine.

C. Bucana, I. Fidler, R. Radinsky, 1996, Cancer biotherapy & radiopharmaceuticals.

Immunochemistry of the K antigens of Escherichia coli. The K87 antigen from Escherichia coli 08:K87(B?):H19.

L. Tarcsay, K. Jann, B. Jann, 1971, European journal of biochemistry.

Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis

R. G. Clerc, C. Sorg, K. Odink, 1987, Nature.

MTP-PE, a Synthetic Lipophilic Muramyltripeptide: Biological and Toxcological Properties

D. Braun, T. Skripsky, L. Tarcsay, 1987 .

Different responses of B lymphocyte colony-forming cells in bone marrow and spleen of mice injected with bacterial cell-wall components.

J. Layton, L. Tarcsay, F. Staber, 1979, Journal of immunology.

Origin and fate of IgE-bearing lymphocytes. II. Modulation of IgE isotype expression on Peyer's patch cells by feeding with certain bacteria and bacterial cell wall components or by thymectomy.

H. Bazin, H. Durkin, L. Tarcsay, 1989, Journal of immunology.

Control of IgE responses.

H. Bazin, H. Durkin, M. Smith, 1989, Clinical immunology and immunopathology.

Generation and characterization of a monoclonal antibody (1C5) to human migration inhibitory factor (MIF).

C. Sorg, L. Tarcsay, G. Burmeister, 1986, Immunobiology.

The molecular nature of the cystic fibrosis antigen

G. Holländer, M. Rutishauser, C. Sorg, 1988, Nature.

Modulation of Myelopoiesis In Vivo by Chemically Pure Preparations of Cell Wall Components from Gram-Negative Bacteria: Effects at Different Stages

L. Tarcsay, P. Dukor, F. Staber, 1978, Infection and immunity.

Modulation of myelopoiesis by different bacterial cell-wall components: induction of colony-stimulating activity (by pure preparations, low-molecular-weight degradation products, and a synthetic low-molecular analog of bacterial cell-wall components) in vitro.

L. Tarcsay, G. Schumann, P. Dukor, 1978, Cellular immunology.

Chapter 15 Immunostimulants

L. Tarcsay, P. Dukor, G. Baschang, 1979 .

New developments in drugs enhancing the immune response: activation of lymphocytes and accessory cells by muramyl-dipeptides

E. D. Wachsmuth, L. Tarcsay, F. Dietrich, 1979 .

Reaction of lectins with human erythrocytes. III. Surface charge density and agglutination.

C. Roeder, L. Tarcsay, H. Schnebli, 1976, Experimental cell research.

Analysis of the antimetastatic effects of synthetic muramyl tripeptide (CGP 19835A) encapsulated in liposomes in combination with other immunomodulatory agents and chemotherapeutic drugs.

P. Furmanski, J. Bezault, H. Frost, 1993, In vivo.

Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma.

V. Diehl, J. Delabie, B. de Strooper, 1992, Blood.

Efficacy of liposomes containing a lipophilic muramyl dipeptide derivative for activating the tumoricidal properties of alveolar macrophages in vivo

I. Fidler, S. Sone, A. Schroit, 1982 .

Specific impaired alloreactivity of mice immunized with syngeneic MLCT-lymphoblasts using muramylpeptides as adjuvant.

H. Binz, H. Wigzell, L. Tarcsay, 1981, Transplantation proceedings.

Restin: a novel intermediate filament‐associated protein highly expressed in the Reed‐Sternberg cells of Hodgkin's disease.

J. Delabie, F. Asselbergs, R. Shipman, 1992, The EMBO journal.